| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 90 |
| 1 | METHOTREXATE SODIUM | 90 |
| 2 | DEXAMETHASONE 1.5 MG | 88 |
| 3 | METHOTREXATE | 85 |
| 4 | BORTEZOMIB | 63 |
| 5 | HYDROXYCHLOROQUINE SULFATE | 62 |
| 6 | HYDROXYCHLOROQUINE | 60 |
| 7 | CYCLOPHOSPHAMIDE | 54 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 54 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 54 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TELISOTUZUMAB VEDOTIN | 2 | 0.0256 |
| 1 | MIRVETUXIMAB SORAVTANSINE | 46 | 0.0254 |
| 2 | ERDAFITINIB | 18 | 0.0144 |
| 3 | NATAMYCIN | 5 | 0.0122 |
| 4 | PENPULIMAB | 1 | 0.0102 |
| 5 | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | 2 | 0.0099 |
| 6 | CODEINE PHOSPHATE AND GUAIFENESIN | 1 | 0.0093 |
| 7 | METHOXSALEN | 1 | 0.0079 |
| 8 | DATOPOTAMAB DERUXTECAN | 6 | 0.0070 |
| 9 | CEFUROXIME SODIUM | 8 | 0.0065 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 168 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 102 |
| 2 | Platinum-based Drug [EPC] | 84 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 68 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 65 |
| 5 | Proteasome Inhibitor [EPC] | 65 |
| 6 | Alkylating Drug [EPC] | 63 |
| 7 | Kinase Inhibitor [EPC] | 53 |
| 8 | Antirheumatic Agent [EPC] | 51 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 35 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Polyene Antimicrobial [EPC] | 5 | 0.0122 |
| 1 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 2 | Antiseptic [EPC] | 12 | 0.0027 |
| 3 | Rifamycin Antimycobacterial [EPC] | 6 | 0.0017 |
| 4 | Quinolone Antimicrobial [EPC] | 11 | 0.0011 |
| 5 | Antimycobacterial [EPC] | 27 | 0.0011 |
| 6 | Interferon alfa-2b [EPC] | 2 | 0.0011 |
| 7 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 8 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 35 | 0.0007 |